Ovarian cancer—in vitro studies using ovarian cancer cell lines with knockdown or overexpression of CHAF1A (chromatin assembly factor 1 unit A) that induces cell proliferation and growth, showed an inhibitory effect of Peficitinib [51]. Here, CHAF1A is linked to ovarian cancer.